© Brian Snyder/Reuters

This article picked by a teacher with suggested questions is part of the Financial Times free schools access programme. Details/registration here.

Read all our psychology class picks.


  • Schizophrenia

Click the link below to read the and then answer the questions:

Indivior aims to move primary listing from London to New York

  • Indivior, the company discussed in the article, produces medication for schizophrenia. Explain how antipsychotics work. You may wish to draw a diagram

  • Distinguish between typical and atypical drugs as used in the treatment of schizophrenia

  • Explain two limitations of drug therapy for schizophrenia

  • The article gives Indivior’s adjusted net income of over $220mn for 2023. Some of this may be used to fund research into drug therapy. Explain what is meant by publication bias

  • In 2020, the company agreed to a large settlement based on false safety claims about one of their (anti-addiction) drugs. To what extent do side effects undermine the effectiveness and appropriateness of schizophrenia medication?

Danny Galbraith, St Bartholomew’s School

Copyright The Financial Times Limited 2024. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Follow the topics in this article